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SUMMARY
Aim: To report a rare case of anterior hyaloidal fibrovascular
proliferation (AHFVP) which occurred after cataract surgery
on a non-vitrectomized diabetic eye. This complication
resulted in vitreous haemorrhage and hyphaema following a
YAG laser capsulotomy procedure.
Method: A case report of a patient managed at the above eye
department. Clinical records as indicated in the patient’s case
note were reported.
Conclusion: Anterior hyaloidal fibrovascular proliferation is a
complication which an eye surgeon should bear in mind when
attending to diabetic eyes after cataract surgery. The potential
danger of  vitreous haemorrhage following YAG laser
capsulotomy should also be borne in mind, as more centres in
the country aspire to acquire a YAG laser machine to perform
capsulotomy.
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INTRODUCTION 
Anterior hyaloidal fibrovascular proliferation (AHFVP) is a
well recognized complication occurring in eyes that have
undergone diabetic vitrectomy.  1, 2
It most commonly occurs after phakic vitrectomy and
scleral buckling for diabetic traction retinal detachment. It
usually manifests with haemorrhage into the vitreous cavity
or anterior hyaloid 3 to 12 weeks after vitrectomy and is the
result of fibrovascular proliferation from the peripheral
retina extending toward the equator of the lens and on to the
posterior lens capsule.  Patients who develop AHFVP3, 4
typically have long-standing diabetes, extensive retina
ischaemia and florid neovascularization despite panretinal
photocoagulation. 
Although AHFVP is commonly seen in post vitrec-
tomized diabetic eyes, it is a rather uncommon occurrence
after a cataract extraction. Medline search revealed only one
reported case series of AHFVP which occurred after  cataract
surgery with implantation of a posterior chamber intraocular
lens in four patients.4
Anterior  hyaloidal fibrovascular proliferation occurs in
the retrolenticular or ciliary body region.  Typically,5,6
fibrovascular proliferation in ischaemic diabetic eyes is
known to occur predominantly in the region posterior to the
equator, ie, the pre-equatorial fundus.  There is a5
preponderance of posterior neovascularization occurring in
proliferative diabetic retinopathy. This posterior7,8,9  
proliferative disease in ischaemic diabetic eyes, in turn,
could  result in vitreoretinal tractional forces, giving rise to
the well known tractional or tractional-rhegmatogenous
retinal detachment of the posterior pole seen in proliferative
diabetic retinopathy. Fibrovascular proliferation in
proliferative diabetic retinopathy occurring in the pre
equatorial fundus, ie, the fundus anterior to the equator, is
a more unusual finding .  5
The case being reported is unique for two reasons.
Firstly, the patient suffered from fibrovascular proliferation
occurring in a region of the fundus that is rather uncommon
in a diabetic eye. Secondly, that this complication occurred
after cataract surgery, without previous vitrectomy is also
unusual.
The development of anterior hyaloidal fibrovascular
proliferation in diabetic eyes after cataract extraction,
combined with the occurrence of a posterior capsular opacity
in patients could be a challenge to the eye surgeon. Firstly,
detailed viewing and examination of the fundus may be
hindered by the posterior capsular opacity. Adequate retinal
laser photocoagulation to treat this condition may be limited
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by capsular opacity. Retinal cryotherapy to the peripheral
retina may be an option. However, YAG laser capsulotomy
may induce vitreous haemorrhage and accelerate the
formation of rubeosis iridis and anterior segment
neovascularization because angiogenic factors from the
posterior segment can now cross the capsular barrier into the
anterior segment. As more eye departments acquire a YAG
laser machine and perform capsulotomies this complication
may be encountered more often.
AIM
To report a rare case of anterior proliferative disease
occurring in the form of anterior hyaloidal fibrovascular
proliferation in a diabetic eye after cataract surgery. In this
patient, the complication resulted in vitreous haemorrhage
and hyphaema during YAG laser posterior capsulotomy.
This patient had undergone cataract surgery with posterior
chamber intraocular lens insertion 8 months earlier. This
report also aims to sensitize eye surgeons who may be
performing  YAG laser procedures on diabetic eyes to be
aware of the possibility of this complication occurring after
cataract surgery and not only after vitrectomy procedure as
is commonly observed and documented in published
literature.
The importance of a satisfactory control of the blood
sugar level and other systemic indices including the blood
pressure, pre- and post-operatively is to be stressed in
diabetic patients scheduled to undergo removal of cataract. 
CASE PRESENTATION
A 55-year-old male non insulin dependent diabetic
(diagnosed 10 years prior to presentation) presented to the
retina clinic on the 6  of March 2006, with the complaint ofth
a one-year history of cloudy vision in his left eye. He had
noticed a gradual painless clouding of his left eye vision.
Examination revealed right eye visual acuity of 6/9 and left
eye visual acuity of 6/36 unaided. Left eye visual acuity was
improved to 6/18 with correction. Intraocular pressure (IOP)
was 10mmHg in both eyes. No detailed view of the fundus
could be seen in the left eye due to a visually significant
cataract. An early cataract was noted in the right eye and
funduscopy revealed right eye macular hard exudates and
haemorrhage (fig. 1). 
Fasting Blood Sugar
The patient had 337 mg/dl (markedly elevated)/BP:
160/90mmhg (systolic hypertension). The PCV was 32%;
urinalysis did show 4+ glucose and 3+ protein. No ketones
were present in the urine.  He was advised to institute strict
control of blood sugar and see his physician for the control
of systemic indices before surgery to remove cataract. He
was seen again on the 18  of April 2006 and confirmed thatth
he had been certified fit for surgery by his attending
physician. 
  Figure 1.  Showing  right  eye  fundus  with  macular hard
   exudates and  dot haemorrhage.
Subsequently, he underwent a left eye
phacoemulsification of cataract and insertion of a posterior
chamber intraocular lens. Intraoperatively, as the lens
nucleus was hard and difficult to phacoemulsify completely,
there was an intraoperative conversion to extracapsular
cataract extraction, with wound extension and the remains
of the nuclear fragment was delivered manually. Procedure
was otherwise uneventful and the posterior lens capsule was
intact. Post operative visual acuity at one month was 6/18
unaided and 6/9 aided. At this visit, clinically significant
diabetic macular oedema was noted in the left eye (see fig. 2).
He did undergo focal retina laser photocoagulation to this
eye during the same visit (at the 1  month post surgery).st
  Figure 2.  Showing  left eye clinically significant macular
  oedema with a  hard exudate. 
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He defaulted on his clinic appointment and was seen 7
months later. 
Then he complained of poor vision in the left eye. A
significant posterior capsular opacification was noted behind
the intraocular lens with vision of 6/18 unaided and 6/18+
with a pinhole in the left eye. His IOP was 18mmHg in the
left eye on this visit. Upon direct questioning, he admitted to
not having achieved a satisfactory glycaemic and alcohol
intake control. There was no evidence of rubeosis on the iris
surface.
YAG laser capsulotomy was performed, and during this
procedure, haemorrhage was noted from a superior location
behind the posterior capsule, into the anterior vitreous. This
resulted in a vitreous haemorrhage and a diffuse hyphaema
with reduction in visual acuity to PL.
Ultrasonography revealed a vitreous haemorrhage and
anterior hyaloidal proliferation seen as echogenicity
predominantly in the anterior vitreous, with a track of the
haemorrhage extending from behind the anterior vitreous to
the posterior vitreous. 
On slit lamp examination, the gap created in the
posterior capsule during the YAG laser procedure was
covered by a blood clot.  
Diffuse hyphaema cleared by the next day, but the
vitreous haemorrhage persisted. Despite surgical efforts
made at salvaging this eye, all vision was eventually lost. 
DISCUSSION 
Anterior hyaloidal fibrovascular proliferation has been
reported as the most common postoperative complication
following diabetic vitrectomy. In a group of 74 consecutive
eyes that underwent vitrectomy for complications of diabetic
vitrectomy.1
There have been only few reports of AHFVP occurring
after cataract surgery.  4
This case report provides evidence supporting the
occurrence of this entity in not only post vitrectomized eyes,
but following cataract surgery.
Clinical features of AHFVP include recurrent vitreous
haemorrhages into the vitreous cavity or anterior vitreous or
both vessels or fibrovascular tissue on the posterior lens
capsule (this may have been the case in the patient
presented, but vessels may not have been observed or were
missed because of the capsular opacity), anterior extraretinal
vascularization extending towards the lens on the anterior
hyaloids (this hypothetically may also have occurred in this
case), traction detachment of the peripheral retina or ciliary
body and hypotony.1,3
AHFVP can be diagnosed with the use of ultrasound
biomicroscopy. The echographic appearance has been well
described.2, 6, 10
The usefulness of B Scan ultrasonography in identifying
AHFVP in eyes at risk among diabetic patients who have a
significant posterior capsule thickening following routine
ECCE should be emphasized. A high index of suspicion is
required and risk factors for this entity occurring after ECCE
should be always borne in mind.  4
The risk factors noted for the occurrence of anterior
hyaloidal fibrovascular proliferation after cataract include
proliferative diabetic retinopathy, iris neovascularization
and anterior ischaemic retina.  These three risk factors3
should serve as a caution to eye surgeons as they manage
these patients. This patient had defaulted on his clinic visits
and had not been attentive to proper glycaemic control
during his postoperative period. It is likely he may have
developed proliferative diabetic retinopathy which may not
have been observed, as the examination of the fundus was
limited by the posterior capsule opacity. This being the case,
prompt retinal laser photocoagulation may have been
helpful in the management of his clinical situation had he
been seen before the development of the thickened posterior
capsule. It then becomes important to point out the
usefulness of more frequent and shorter postoperative clinic
appointments for diabetic eyes with a suspicion of poor
glycaemic control. The eyes should probably have had
prompt and more aggressive retinal laser photocoagulation
when proliferative disease was noted. Patients and surgeons
should be aware of this, just as the importance of
postoperative maintenance of strict glycaemic control by the
physician should be stressed. The patient should maintain
satisfactory control of his blood sugar and other systemic
indices not only before the cataract surgery, but equally after
the cataract surgery.   
It is important to stress the following three points. First,
identification of growing vessels or fibrovascular tissue on
the posterior lens capsule after cataract surgery (as can be
seen in AHFVP), in a patient who presents with a posterior
capsule thickening may pose a considerable challenge.
Secondly, the fibrovascular growth on the posterior lens
capsule could also result in a worsening of the posterior
capsular opacity, further obscuring the visualization of the
growing vessels or fibrovascular tissue. Thirdly, an opaque
posterior capsule would prevent adequate retinal
examination and could prevent detection of proliferative
diabetic retinopathy which is a recognized risk factor for the
occurrence of AHFVP after cataract surgery.4
Caution should be used before scheduling this category
of eyes with AHFVP for routine YAG laser capsulotomy.
Such conditions will benefit more from aggressive retinal
laser photocoagulation, or retinal cryotherapy (if the view of
the fundus is obscured) or surgical management by a
vitreoretinal unit. YAG laser capsulotomy in this group of4 
patients with AHFVP can only result in vitreous
haemorrhage and hyphaema, as seen in the case reported
and should be avoided if possible. 
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In the early stages of AHFVP, visual acuity may be
unaffected. It is instructive to note that the patient still had
a visual acuity of 6/18 despite having this complication.
Also, this complication had developed within 8 months
following cataract surgery in a poorly controlled diabetic.
This is a shorter duration than the 12-month average
previously reported in 4 patients.  This may have been as a3
result of the extremely poor control of the patients’ blood
sugar within the 8-month period, when he defaulted his
clinic visit. A similar report of this complication occurring in
4 patients with proliferative diabetic retinopathy after ECCE
and PCIOL noted that it affected the vision in only one of
four patients.  This case corroborates the findings that vision3
could still be good in a pseudophakia, despite this
complication. With vision being unaffected early in the
disease the patient may have no initial vision-related
complaints during clinic visits. Yet it is at this early stage of
the disease that treatment must be instituted if the eye is to
be saved. Therefore, the predisposing factors for this disease
must be borne in mind and the ophthalmic surgeon
confronted with this category of patients should have a high
index of suspicion for its occurrence. 
Generally, this case points out the difficulties and
challenges that could be encountered in a clinical situation of
significant posterior capsule-thickening and occurrence of
AHFVP following cataract surgery in diabetic eyes. A high
index of suspicion should be borne in mind in diabetic
patients who still have a poor control of blood sugar after
cataract surgery. Appropriate attention should be given to
the standard care of a diabetic, and good control of the blood
sugar is required not only pre-operatively, but should be
continued post-operatively. To manage this condition, if
detected early in eyes with a clear media requires a timely
additional extensive retinal laser photocoagulation applied
to the posterior and anterior retina.  Cryotherapy to the3
retina periphery can be useful if the media is hindered by a
posterior capsular opacity.  
YAG laser capsulotomy should be performed with
caution in the setting of the AHFVP and a significant
posterior capsule opacity as vitreous haemorrhage and
hyphaema may complicate such cases.
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